RxDoctor Payments Data

Lori Bridges, PA

Physician Assistant · Raleigh, NCNPI 1366473043

Payments from drug & device makers

$1,167in general payments, 2019–2025

Across 67 payments — averaging $17.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$357
  • Abbott$192
  • Lilly USA, LLC$176
  • GSK$57
  • Boehringer Ingelheim$45
  • Pfizer$42
  • plus $298 from 14 others

What the payments were for

  • Food & beverage$1,167100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,167 in reported general payments places this provider in the 70th percentile of 7,441 physician assistant providers in North Carolina.

See all physician assistant providers in North Carolina

Medicare billing

Part B allowed, 2024
$112,309
Medicare patients
177
Services billed
4,552

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide105$125,019
EliquisApixaban59$55,206
JardianceEmpagliflozin31$38,533
TrulicityDulaglutide33$31,144
RybelsusSemaglutide20$30,523
MounjaroTirzepatide29$28,983
JanuviaSitagliptin Phosphate25$24,167
FarxigaDapagliflozin Propanediol21$20,009
Tresiba Flextouch U-100Insulin Degludec17$17,120
Omnipod Dash Pods (Gen 4)Insulin Pump Cart,cont Inf,bt17$15,277
Tresiba Flextouch U-200Insulin Degludec19$13,398
MyrbetriqMirabegron17$12,094
Novolog FlexpenInsulin Aspart19$4,684
SynthroidLevothyroxine Sodium40$3,381
Levothyroxine Sodium297$3,314

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$357$155,542125 claims
Lilly USA, LLCTrulicity, Mounjaro$176$60,12662 claims
PfizerEliquis, Paxlovid$42$56,63671 claims
Boehringer IngelheimJardiance$45$38,53331 claims
MerckJanuvia$15$24,16725 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 7,441 physician assistant providers in North Carolina.

Other physician assistant in Raleigh

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →